Collisions between replication forks and topoisomerase-drug-DNA ternary complexes result in the inhibition of DNA replication and the conversion of the normally reversible ternary complex to a nonreversible form. Ultimately, this can lead to the double strand break formation and subsequent cell death. To understand the molecular mechanisms of replication fork arrest by the ternary complexes, we have investigated molecular events during collisions between DNA helicases and topoisomerase-DNA complexes. A strand displacement assay was employed to assess the effect of topoisomerase IV (Topo IV)-norfloxacin-DNA ternary complexes on the DnaB, T7 gene 4 protein, SV40 T-antigen, and UvrD DNA helicases. The ternary complexes inhibited the strand displacement activities of these DNA helicases. Unlike replication fork arrest, however, this general inhibition of DNA helicases by Topo IV-norfloxacin-DNA ternary complexes did not require the cleavage and reunion activity of Topo IV. We also examined the reversibility of the ternary complexes after collisions with these DNA helicases. UvrD converted the ternary complex to a nonreversible form, whereas DnaB, T7 gene 4 protein, and SV40 T-antigen did not. These results suggest that the inhibition of DnaB translocation may be sufficient to arrest the replication fork progression but it is not sufficient to generate cytotoxic DNA lesion.
Topoisomerases are the essential enzymes found in all living cells. They are responsible for altering the topology of DNA by catalyzing the passage of DNA strands and helices through each other. These enzymes are required for DNA replication, transcription, and recombination. Topoisomerases also play critical roles in chromosome structure, condensation/decondensation, and segregation (1) .
The importance of these enzymes is underscored by the fact that they are the primary cellular targets for many clinically important antibacterial and anticancer drugs. In eukaryotes, these enzymes are the cellular targets of potent anticancer drugs, whereas in prokaryotes both DNA gyrase and topoisomerase IV (Topo IV) 1 are targets of the quinolone antibacterial agents (2) (3) (4) .
Topoisomerases break and rejoin DNA strands by forming a covalent linkage between the enzyme and the DNA at the site of the strand breakage (1) . This covalent topoisomerase-DNA complex (often referred to as a "cleavable complex") is normally a fleeting catalytic intermediate. The DNA helix is thought to be broken in the cleavable complex with the linear integrity of the DNA maintained by the topoisomerase bridge. Some topoisomerase inhibitors convert these essential enzymes into cellular poisons by trapping a cleavable complex as a topoisomerase-drug-DNA ternary complex. Because of this unique mode of action, these topoisomerase inhibitors are often called "topoisomerase poisons" (2) (3) (4) . The poisoning of topoisomerases results in the inhibition of chromosomal DNA replication, formation of double strand breaks (DSBs), and subsequent cell death. Although the formation of the ternary complex is critical for cytotoxicity, these complexes are completely reversible, and the DNA strands can be religated. It has been proposed that an active DNA transaction, such as passage of the DNA replication fork, is required for disruption of the ternary complex to generate a nonreversible cytotoxic DNA lesion, a DSB (2-4). However, the exact mechanisms of the replication fork arrest and the DSB formation are not yet clear.
We have modeled the collision between a Topo IV-norfloxacin (Norf)-DNA ternary complex and a replication fork in vitro, using the oriC replication system and either wild type or mutant Topo IV proteins (5) . An active strand cleavage and reunion activity of Topo IV is required for the formation of a ternary complex that can arrest replication fork progression. Interestingly, the collision between a topoisomerase-quinolone-DNA ternary complex and a replication fork converted the ternary complex to a nonreversible form but did not generate a DSB. An additional step was required for the generation of a DSB. Thus, the cytotoxicity associated with these topoisomerase poisons is likely to require two steps: (i) conversion of a topoisomerasequinolone-DNA ternary complex to a nonreversible form as a result of the collision between a ternary complex and a replication fork and (ii) generation of a DSB by subsequent denaturation of the topoisomerase in the dead end complex, perhaps by an aborted repair attempt (5) .
To further determine molecular mechanisms of replication fork arrest by topoisomerase-quinolone-DNA ternary complexes and generation of DSBs, we investigated the consequences of the collisions between topoisomerase complexes and DNA helicases. We found that a Topo IV-Norf-DNA ternary complex inhibited the activities of the DnaB, T7 gene 4 protein, SV40 large T-antigen (T-ag), and UvrD DNA helicases. Interestingly, unlike replication fork arrest, the strand cleavage and reunion activity of Topo IV was not required for this general inhibition of DNA helicases by the ternary complex. The encounter of UvrD with a Topo IV-Norf-DNA ternary complex converted the ternary complex to a nonreversible form, whereas that of the DnaB, T7 gene 4 protein, and SV40 T-ag helicases did not. These results suggest that inhibition of DnaB translocation by the topoisomerase-quinolone-DNA ternary complex may arrest the replication fork progression but the collision of DnaB alone is not sufficient to disrupt the topoisomerase complex and generate DSBs. oligonucleotides containing a 40-nucleotide (nt) defined Topo IV binding site (underlined; see Ref. 6), T440-top (5Ј-AATTCTTGTTATCGCGACACACTCCTAAAAATCCGGGGTA-TACCCCGGATTTTTAGGAGTCTAGATACGAGCCGGA-3Ј) and T440-bottom (5Ј-AGCTTCCGGCTCGTATCTAGACTCCTAAAAATCCGGG-GTATACCCCGGATTTTTAGGAGTGTGTCGCGATAACAAG-3Ј) , were synthesized and annealed to each other to form a short duplex (referred to as T440). A recombinant M13 containing a 40-base pair (bp) defined Topo IV binding site was constructed by cloning the T440 duplex DNA into EcoRI/HindIII-digested M13mp18 (M13-T440). The singlestranded circular DNA of M13-T440 was prepared as described previously (7, 8) .
MATERIALS AND METHODS

DNAs and Proteins-Two
The wild type, a quinolone-resistant Topo IV, ParC S80L Topo IV, and a catalytically inactive Topo IV, ParC Y120F Topo IV, were prepared according to Hiasa et al. (5) . Purified Topo IV, DnaB, and UvrD were the gift of Kenneth Marians (Memorial Sloan-Kettering Cancer Center). Purified SV40 T-ag, T7 gene 4 protein, and UvrD helicases were generous gifts of Jerard Hurwitz (Memorial Sloan-Kettering Cancer Center), Smita Patel (Ohio State University), and Steve Matson (University of North Carolina), respectively.
Restriction enzymes and DNA modifying enzymes were from New England Biolabs, Roche Boehringer Mannheim, Stratagene, and Amersham Pharmacia Biotech.
Preparation of Helicase Substrates-Partial duplex DNAs were prepared as described previously (9) . Briefly, a 62-nt oligonucleotide, T440C (5Ј-GCTCGTATCTAGACTCCTAAAAATCCGGGGTATACCCC-GGATTTTTAGGAGTGTGTCGCGAT-3Ј) was synthesized and hybridized to the M13-T440 single-stranded DNA to prepare a primer-template. The oligonucleotide in the primer-template was then 3Ј-endlabeled by incorporation of 2 residues of [ 32 P]dAMP (ICN) with Klenow enzyme. We referred to this partial duplex DNA as 3Ј-T440 (Fig. 1A) . When required, a 3Ј-heteropolymeric tail having an average length of 30 nt was added to the annealed oligonucleotide using terminal deoxynucleotidyltransferase (referred to as 3Ј-T440T) (Fig. 1A) . Oligonucleotides T440C and T440CT (5Ј-TCGTATCTAGACTCCTAAAAATCC-GGGGTATACCCCGGATTTTTAGGAGTGTGTCGCGATATGGTTCA-GCTAGCG-3Ј) were 5Ј-end-labeled using T4 polynucleotide kinase and [␥-32 P]ATP (ICN) and then hybridized to the M13-T440 single-stranded DNA to prepare the 5Ј-end-labeled partial duplex DNAs. These substrates were referred to as 5Ј-T440 and 5Ј-T440T, respectively (Fig. 1B) .
Topo IV-catalyzed Cleavage Assay-Reaction mixtures (12.5 l) containing 50 mM Tris-HCl (pH 7.5 at 23°C), 10 mM magnesium chloride, 10 mM dithiothreitol (DTT), 50 g/ml bovine serum albumin (BSA), 2 mM ATP, 10 fmol (as molecule) of substrate 3Ј-T440, 300 fmol of Topo IV, and the indicated concentrations of Norf were incubated at 37°C for 10 min. SDS was then added to 1%, and the reaction mixtures were incubated at 37°C for 5 min. EDTA and proteinase K were then added to 25 mM and 100 g/ml, respectively, and the incubation was continued for an additional 15 min. The DNA products were purified by extraction of the reaction mixtures with phenol-chloroform (1:1, v/v), heat-denatured by heating at 95°C for 5 min, and then analyzed by electrophoresis through 8 and 10% polyacrylamide (19:1, acrylamide/bisacrylamide) gels (140 ϫ 160 ϫ 1.2 mm) at 12 V/cm for 2 h using 50 mM Tris borate (pH 8.3) and 1 mM EDTA as the electrophoresis buffer (TBE buffer). Gels were dried under vacuum onto DE81 paper (Whatman) and autoradiographed with Hyperfilm MP (Amersham Pharmacia Biotech). Strand displacement was quantitated by scanning images by a STORM 840 PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) and scanning films by the Eagle Eye II Jr. system (Stratagene).
Strand Displacement Assays-For the DnaB (9, 10) and T7 gene 4 protein helicase assays, standard reaction mixtures (12.5 l) contained 40 mM Hepes-KOH (pH 7.6 at 23°C), 10 mM magnesium acetate, 3.5 mM ATP, 10 mM DTT, 50 g/ml BSA, 10 fmol (as molecule) of DNA substrate (either 3Ј-T440T or 5Ј-T440T), and the indicated amounts of Norf. Three hundred fmol (as tetramer) of Topo IV was first bound to the DNA in a first stage incubation of 5 min at 37°C. DnaB (250 fmol as hexamer) or T7 gene 4 protein (250 fmol as hexamer) was then added, and the reaction mixtures were incubated during the second stage for 10 min at 37°C.
SV40 T-ag helicase activity was assayed (11) in reaction mixtures (12.5 l) containing 50 mM Tris-HCl (pH 7.5 at 23°C), 50 mM potassium glutamate, 10 mM magnesium chloride, 100 mM DTT, 10 g/ml BSA, 2 mM ATP, and 10 fmol of DNA substrate (either 3Ј-T440 or 5Ј-T440). During the first stage of incubation, 300 fmol (as tetramer) of Topo IV was bound to the DNA. Then, 500 fmol (as hexamer) of SV40 T-ag helicase was added, and the second stage of the incubation was continued at 37°C for 10 min.
The helicase activity of UvrD was assessed (9, 12) in standard reaction mixtures (12.5 l) containing 50 mM Tris-HCl (pH 7.5 at 23°C), 10 mM magnesium chloride, 10 mM DTT, 50 g/ml BSA, and 2 mM ATP. Ten fmol of DNA substrate (either 3Ј-T440 or 5Ј-T440) was added, to which 300 fmol (as tetramer) of Topo IV protein was bound by incubating at 37°C for 5 min. After the first incubation stage, 125 fmol (as dimer) of UvrD helicase was added, and then the reaction mixtures were incubated at 37°C for an additional 10 min.
As described above, substrates 5Ј-T440T and 3Ј-T440T were used in the helicase assays for DnaB and T7 gene 4 protein, and 5Ј-T440 and 3Ј-T440 were used for SV40 T-ag and UvrD. We obtained virtually identical results with either substrate (data not shown).
Reactions were terminated by adding EDTA to 25 mM, followed by the addition of a quarter volume of a dye mixture containing 15% glycerol, 2% sarkosyl, 0.05% xylene cyanol, 0.05% bromphenol blue, and 50 mM EDTA. Aliquots were analyzed by electrophoresis through vertical 1% agarose (Seakem ME, FMC) gels (140 ϫ 120 ϫ 3 mm) at 5 V/cm for 2 h in a running buffer of 50 mM Tris-HCl (pH 7.9 at 23°C), 40 mM sodium acetate, and 1 mM EDTA (TAE buffer). Gels were dried under vacuum onto DE81 paper (Whatman) and autoradiographed with Hyperfilm MP (Amersham Pharmacia Biotech). Strand displacement was quantitated by scanning images by a STORM 840 PhosphorImager (Molecular Dynamics) and scanning films by the Eagle Eye II Jr. system (Stratagene).
Reversal Assay for the Topo IV-Quinolone-DNA Ternary ComplexThe reversibility of the topoisomerase complexes after their collision with DNA helicases was assessed by combining the strand displacement assay and the reversal assay (5) . Reaction mixtures were assembled as described above, and Topo IV was bound to the partial duplex DNA in the presence of Norf during the first stage of incubation at 37°C for 5 min. Reaction mixtures were then incubated at 37°C for 10 min in the presence and absence of a DNA helicase. This assay allowed a DNA helicase to collide with a Topo IV-Norf-DNA ternary complex formed at the defined Topo IV binding site. Reactions were terminated by adding either EDTA or SDS to 25 mM and 1%, respectively, and incubating at 37°C for 5 min. Either SDS or EDTA, together with proteinase K, was then added to each reaction mixture to a final concentration of 1%, 25 mM, and 100 g/ml, respectively. The incubation was further continued at 37°C for an additional 15 min. The DNA products were purified by extraction of the reaction mixtures with phenol-chloroform (1:1, v/v), heat-denatured by heating at 95°C for 5 min, and then analyzed by electrophoresis through 10% polyacrylamide (19:1, acrylamide/bisacrylamide) gels (140 ϫ 160 ϫ 1.2 mm) at 12 V/cm for 2 h using TBE buffer. Gels were dried and analyzed as described above.
RESULTS
Partial Duplex DNAs-In our previous studies (6), we defined a preferred Topo IV binding site based on the DNA sequences of Norf-induced, Topo IV-catalyzed DNA cleavage sites on a plasmid DNA. Two oligonucleotides of 24 and 50 nt in length containing this defined Topo IV binding site have been designed as perfect palindromes with the cleavage sites offset 2 nt from the center. The wild type and various mutant Topo IV proteins bind to these short duplex DNAs, and their bindings are stimulated by Norf (6) .
We constructed a recombinant M13 that contained the 40-bp defined Topo IV binding site (M13-T440) and prepared its single-stranded DNA. Partial duplex DNAs were prepared by annealing short oligonucleotides complementary to the cloned Topo IV binding site to the M13-T440 single-stranded DNA. On these partial duplex DNAs, the 40-bp-long Topo IV binding site was located in the middle of the duplex region (61-64 bp long) flanked by 10 -12-bp spacer sequences at both sides ( Fig. 1) .
First, we examined the stimulation of Topo IV-catalyzed cleavages by Norf using a partial duplex DNA 3Ј-T440 as the substrate (Fig. 2) . As expected, we observed a unique cleavage of the annealed oligonucleotide as a result of a Norf-stimulated, Topo IV-catalyzed cleavage ( Fig. 2A) . There was an additional weak cleavage (about 5-15% of the cleaved DNA) that was observed only at high concentrations of Norf. The stimulation of Topo IV-catalyzed cleavage of a partial duplex by Norf (Fig.  2B ) was very similar to that of a short duplex DNA containing the same defined Topo IV binding site (6) . These results demonstrated that the Norf-stimulated Topo IV-catalyzed DNA cleavages ( Fig. 2 ) and the Norf-stimulated Topo IV binding to the DNA (6) coincided with each other. Thus, we assumed that the Topo IV-catalyzed DNA cleavages in the presence of various concentrations of Norf shown in Fig. 2 correlated with the relative amounts of Topo IV-Norf-DNA ternary complexes formed on the partial duplex DNA. The occupancy of the DNA substrate by the Topo IV complex determines the probability of the collision between a DNA helicase and a Topo IV complex. These results also showed that the long single-stranded DNA region of the partial duplex DNA neither sequestered the Topo IV protein nor inhibited Topo IV binding to the short duplex region. In addition, we did not observe DNA cleavages of the long single-stranded region of the partial duplex DNA (data not shown). These results were consistent with the observation that Topo IV does not bind to single-stranded DNA (13) . Thus, we concluded that Topo IV could bind to and form both a binary and ternary complex at the short duplex region of the partial duplex DNA. Furthermore, because of the length of the duplex region, it is likely that only one molecule of Topo IV protein could bind to each partial duplex DNA. Thus, this system allowed us to monitor the molecular events during the collision of a DNA helicase with a Topo IV-Norf-DNA ternary complex at the defined position. We therefore investigated the effects of topoisomerase complexes on the activities of DNA helicases by using the strand displacement assay.
Topo IV-Quinolone-DNA Ternary Complexes Inhibit Strand Displacement Activities of DNA Helicases-Using oriC replication reconstituted with purified proteins, we have shown that the collision between a replication fork and a Topo IV-Norf-DNA ternary complex results in both replication fork arrest and the conversion of a normally reversible ternary complex to a nonreversible form (5) . To further investigate the mechanisms of replication fork arrest, we examined the effects of a Topo IV-Norf-DNA ternary complex on DNA helicases. Among the components of the replication fork, the DNA helicase is first to encounter any roadblock on the parental duplex DNA during chromosomal DNA replication. The DnaB protein is the replicative helicase in Escherichia coli (10) . Recent studies have demonstrated that DnaB forms a hexameric ring around the lagging strand template while translocating in the 5Ј 3 3Ј direction (10, 14 -16) .
We first assessed the effects of the Topo IV-Norf-DNA ternary complex on the DnaB helicase using a strand displacement assay (Fig. 3A) . DnaB could displace about 60% of a short oligonucleotide from the partial duplex DNA under the conditions used (Fig. 3A, lane 4) . Norf alone did not affect the activity of DnaB. In the absence of Norf, the binding of Topo IV inhibited DnaB activity by 50% in this assay (Fig. 3A, lane 6) . A catalytically inactive Topo IV alone also partially inhibited DnaB activity (data not shown). This may be because of the A, DNA cleavage assays using wild type Topo IV, substrate 3Ј-T440, and the indicated concentrations of Norf were performed and analyzed as described under "Materials and Methods." B, the extent of the cleavage as a function of the Norf concentration was quantitated using a PhosphorImager. sensitivity of the DnaB translocation activity to the presence of proteins bound to duplex DNA that we have observed during previous studies on the effect of Tus protein on DNA helicases (9) . Formation of a Topo IV-Norf-DNA ternary complex resulted in an 80% inhibition (Fig. 3A, lane 7) . These results showed that a Topo IV-Norf-DNA ternary complex blocked the passage of the DnaB helicase. These results suggest that replication fork arrest by a Topo IV-Norf-DNA ternary complex could be due to the inhibition of DnaB translocation.
To examine if the inhibition of helicase activity by a Topo IV-Norf-DNA ternary complex was specific to DnaB or represented a generalized inhibition of DNA helicases, we performed the strand displacement assay with other DNA helicases. The T7 gene 4 protein is another hexameric replicative helicase that translocates in the 5Ј 3 3Ј direction (17, 18) . Thus, biochemically, structurally, and functionally, DnaB and T7 gene 4 protein are homologous to each other.
We assessed the activity of T7 gene 4 protein in the absence and presence of Topo IV and Norf (Fig. 3B) . The T7 gene 4 protein-catalyzed strand displacement activity was severely inhibited (greater than 80%) only when both Topo IV and Norf were present in the reaction mixtures (Fig. 3B, lane 6) . Neither Topo IV nor Norf alone affected the activity of T7 gene 4 protein, and this helicase displaced about 70% of the annealed oligonucleotide under these conditions (Fig. 3B, lane 3) . These results demonstrated that inhibition of helicase activities by a Topo IV-Norf-DNA ternary complex was not specific to DnaB.
In a cleavable complex, Topo IV forms a covalent enzyme-DNA bond at the 5Ј-end of the cleaved DNA strand. Although the topoisomerase-DNA complex is symmetrical, DNA helicases that translocate in the 3Ј 3 5Ј direction would encounter the covalent linkage between the topoisomerase and the DNA at the DSB in the complex. On the other hand, DNA helicases that translocate in the 5Ј 3 3Ј direction would reach an end of the DNA strand. Thus, it is possible that helicase inhibition by the Topo IV-Norf-DNA ternary complex is dependent on the direction in which each DNA helicase approaches the topoisomerase in the ternary complex (i.e. a topoisomerase-quinolone-DNA ternary complex could block DNA helicases that approach from one direction but not from the other). To test this directly, the effect of a Topo IV-Norf-DNA ternary complex on SV40 T-ag was examined. SV40 T-ag also functions in a hexameric form like DnaB and T7 gene 4 protein, but this helicase translocates in the opposite direction (3Ј 3 5Ј) on a DNA strand (19, 20) . We performed the strand displacement assay with SV40 T-ag and found that about 30% of the annealed oligonucleotide was displaced (Fig. 3C, lane 3) . When Topo IV formed a ternary complex with Norf and the DNA, the activity of SV40 T-ag was inhibited greater than 80% (Fig. 3C, lane 6) . Unlike DnaB, Topo IV alone had no effect on SV40 T-ag. However, Norf alone exhibited an inhibitory effect (about 50%) on SV40 T-ag (Fig.  3C, lane 4) . We believed that this inhibition was nonspecific inhibition of protein binding to DNA by Norf. We have noted that Norf specifically inhibits the activities of DNA gyrase and Topo IV in the oriC replication system, but this drug has an inhibitory effect on the binding of DnaA proteins to oriC when it is present at high concentrations. 2 Thus, a Topo IV-Norf-DNA ternary complex could arrest replicative helicases approaching from either direction.
The three DNA helicases described above are hexameric replicative helicases that act processively during the DNA unwinding reaction. In order to determine if the nature of helicase action modulated interactions between Topo IV-Norf-DNA ternary complexes and DNA helicases, we examined the effect of a ternary complex on UvrD, a repair helicase. UvrD is thought to function as a dimer on the DNA and catalyzes the DNA unwinding reaction in a distributive manner (12) . Unlike DnaB and SV40 T-ag, neither Topo IV nor Norf alone had an effect on UvrD-catalyzed strand displacement (Fig. 3D) . UvrD displaced about 70% of the annealed oligonucleotide under these conditions (Fig. 3D, lane 3) . However, its activity was severely inhibited (greater than 80%) by a Topo IV-Norf-DNA ternary complex formed in the duplex region (Fig. 3D, lane 6) . These results showed that a topoisomerase-quinolone-DNA ternary complex acted as a roadblock that inhibited the translocation of DNA helicases in a generalized manner.
Topo IV-Norf-DNA Ternary Complexes Are Still Reversible after Collision with Replicative Helicases-We have demonstrated that the collision between a replication fork and a Topo IV-Norf-DNA ternary complex results not only in replication fork arrest but also in the conversion of the ternary complex to a nonreversible form (5) . In light of this observation, we examined if the encounter of a Topo IV-Norf-DNA ternary complex with a replicative helicase converts the ternary complex to a nonreversible form. We modified the strand displacement assay so that we could also assess the reversibility of the topoisomerase complex after its collision with a DNA helicase (see "Materials and Methods"). After incubation with a DNA helicase in the presence of a ternary complex, reaction mixtures were terminated by adding either EDTA or SDS. EDTA reverses ternary complex formation, and the topoisomerase religates the DNA strands (21) . In contrast, SDS denatures the enzyme in the ternary complex, resulting in the generation of a DSB. The DNA products were deproteinized, heat-denatured, and analyzed by electrophoresis. If the ternary complex is still reversible after collision, incubation with EDTA will reverse the ternary complex, and the annealed oligonucleotide will remain intact. However, if the ternary complex is no longer reversible after collision, even after the incubation with EDTA, denaturation of Topo IV will result in the formation of DSBs and the cleavage of the annealed oligonucleotide.
We analyzed the DNA products by electrophoresis through polyacrylamide gels (Fig. 4) . Collisions of a Topo IV-Norf-DNA ternary complex with DnaB (Fig. 4, lanes 2-5) , T7 gene 4 protein (Fig. 4, lanes 6 -9) , and SV40 T-ag (Fig. 4, lanes 10 -13 ) had no effect on the reversibility of the ternary complexes (Fig.  4, lanes 5, 9, and 13) . These results demonstrated that, although a Topo IV-Norf-DNA ternary complex blocked the passages of both the DnaB helicase and a replication fork, the consequence of the collision of a ternary complex with the DnaB helicase alone was significantly different from that with the same helicase when it was part of the replication fork. The encounter of a replicative helicase alone, unlike that of a replication fork, was not sufficient to generate a cytotoxic DNA lesion by converting a ternary complex to a nonreversible form. This may be due to the distinct characteristics of the DnaB protein when it is incorporated in a replication fork and when it functions by itself. It has been demonstrated that the DnaB helicase moves much faster when it establishes an interaction with the DNA polymerase III holoenzyme at the replication fork (22) . Alternatively, it is possible that the encounter of a topoisomerase-quinolone-DNA ternary complex with a DNA polymerase, but not a DNA helicase, causes the conversion of the ternary complex to a nonreversible form.
Collision between a Topo IV-Norf-DNA Ternary Complex and a UvrD Helicase Results in the Conversion of the Ternary Complex to a Nonreversible Form-
We also assessed the effects of the encounter of a Topo IV-Norf-DNA ternary complex with the UvrD helicase on the reversibility of the ternary complex. In contrast to three replicative helicases (Fig. 4) , the normally reversible ternary complex became completely nonreversible when the UvrD helicase collided with a Topo IV-Norf-DNA ternary complex (Fig. 5) . We used two independent preparations of wild type Topo IV and UvrD and obtained virtually identical results (data not shown). These results were consistent with the previous observations by Howard et al. (23) , demonstrating that the collision of UvrD with a T4 topoisomerasem-AMSA-DNA ternary complex converted the ternary complex to a nonreversible form. In contrast, ternary complexes formed with a quinolone-resistant Topo IV, ParC S80L Topo IV, were still reversible (Fig. 5, lanes 9 and 10) . This quinolone-resistant mutation seems to prevent Topo IV from forming a ternary complex that can arrest the progression of a replication fork (5) and DNA helicases (see below). We did not observed any DNA cleavages when a catalytically inactive Topo IV, ParC Y120F Topo IV, was used (Fig. 5, lanes 11 and 12) . Thus, unlike DnaB and other hexameric helicases, the collision between UvrD and a topoisomerase-quinolone-DNA ternary complex disrupted the topoisomerase complex and converted a normally reversible ternary complex to a nonreversible form.
Inhibition of Helicase Activities Does Not Require the Formation of a Covalent
Topoisomerase-DNA Complex-We have shown here that Topo IV-Norf-DNA ternary complex exhibits a general inhibition of DNA helicases (Fig. 3) . However, the 2 H. Hiasa and K. J. Marians, unpublished data.
FIG. 4.
Collisions between a Topo IV-Norf-DNA ternary complex and replicative helicases do not convert the ternary complex to a nonreversible form. Reversal assays for Topo IV-Norf-DNA ternary complexes in the absence and presence of DnaB (lanes 2-5), T7 gene 4 protein (lanes 6 -9), and SV40 T-ag (lanes 10 -13), as indicated, were performed and analyzed as described under "Materials and Methods." Reaction mixtures shown in lanes 1-9 contained 5Ј-T440T as a substrate and were analyzed through 10% polyacrylamide gels, and those in lanes 10 -13 contained 3Ј-T440 and were analyzed through 8% polyacrylamide gels. DnaB (as hexamer), T7 gene 4 protein (as hexamer), SV40 T-ag (as hexamer), and Topo IV (as tetramer) were present at 25-, 25-, 50-, and 30-fold molar excess over substrate, respectively. Norf was present at 400 M. Lane 1 shows heat-denatured substrate. E and S represent the reactions terminated by the addition of EDTA and SDS, respectively. encounter of DnaB, unlike that of a replication fork (5), with a Topo IV-Norf-DNA ternary complex did not affect the reversibility of the ternary complex (Fig. 4) . On the other hand, the UvrD helicase could, upon collision, convert a Topo IV-Norf-DNA ternary complex to a nonreversible form (Fig. 5) . To determine if there are differences between the mechanisms of replication arrest and helicase inhibition by a topoisomerasequinolone-DNA ternary complex, we further investigated the requirements for helicase inhibition by topoisomerase complexes. To avoid partial inhibitions of DnaB-and SV40 T-agcatalyzed strand displacement activities, by Topo IV alone (Fig.  3A) and Norf alone (Fig. 3C) , respectively, we used T7 gene 4 protein and UvrD helicases in the following experiments.
Helicase activities were measured in the presence of the wild type Topo IV, a quinolone-resistant Topo IV, ParC S80L Topo IV, and a catalytically inactive Topo IV, ParC Y120F Topo IV, either in the absence or presence of Norf (Fig. 6 ). In the absence of Norf, neither the wild type nor mutant Topo IV affected the activities of T7 gene 4 protein protein (Fig. 6A) and UvrD (Fig.  6B) . Formation of a ternary complex with the wild type Topo IV inhibited activities of both helicases (Fig. 6, A and B, lane 4) . A quinolone-resistant mutation, S80L, in the ParC subunit, significantly reduced the inhibitory effects of the ternary complex on DNA helicases (Fig. 6, A and B, lane 6) . Interestingly, a ternary complex formed with ParC Y120F Topo IV inhibited the activities of T7 gene 4 protein (Fig. 6A, lane 8) and UvrD helicases (Fig. 6B, lane 8) . These results demonstrated that the strand cleavage and reunion activity of Topo IV was not required for the inhibition of T7 gene 4 protein and UvrD helicases by the Topo IV-Norf-DNA ternary complex. Note that the ParC Y120F Topo IV-Norf-DNA ternary complex cannot arrest replication fork progression (5) . Furthermore, these results suggest that replication fork arrest may be due to the inhibition of the DnaB helicase by the topoisomerase-quinolone-DNA ternary complex. However, collisions between the ternary complexes and the DnaB helicase do not result in the disruption of the topoisomerase complexes and the formation of DSBs.
DISCUSSION
Topoisomerases catalyze strand cleavage and rejoining reactions by forming a covalent linkage between the enzyme and the DNA at the site of strand breakage (1). The cleavable complex, a covalent topoisomerase-DNA complex, is normally a fleeting catalytic intermediate. The steady-state level of the cleavable complex depends on the cleavage religation equilibrium. If the equilibrium is shifted to either stimulate strand cleavage or inhibit religation, the cleavable complex that contains broken DNA strands can persist on the DNA, as if the topoisomerase were trapped in the cleavable complex. Thus, although topoisomerases are essential enzymes in DNA metabolism, these enzymes pose a potential danger to the genome (2-4).
DNA gyrase was recognized, shortly after its discovery (24 -26) , as the cellular target of the quinolone antibacterial drugs (24, 27) . Kreuzer and Cozzarelli (21) have shown that quinolones block DNA replication not by depriving the cell of DNA gyrase but by converting DNA gyrase into a poison of DNA replication. The poisoning of topoisomerases is mediated by trapping of a cleavable complex as a topoisomerase-drug-DNA ternary complex. Disruption of the ternary complexes leads to the generation of DSBs and subsequent cell death (2-4) . The cytotoxicity of topoisomerase poisons is correlated with the FIG. 5. UvrD converts a Topo IV-Norf-DNA ternary complex to a nonreversible form upon its collision with the ternary complex. Reversal assays for the wild type and mutant Topo IV complexes in the absence and presence of Norf and the UvrD helicase, as indicated, were performed and analyzed as described under "Materials and Methods." Lane 1 in all panels was heat-denatured substrate. UvrD (as dimer) and Topo IV proteins (as tetramer) were present at 12.5-and 30-fold molar excess over substrate, respectively. Norf was at 400M when present. wt, wild type Topo IV; S80L, ParC S80L Topo IV; Y120F, ParC Y120F Topo IV. E and S are as in the legend to Fig. 4.  FIG. 6 . Helicase inhibition by the Topo IV-Norf-DNA ternary complex does not require the cleavage and reunion activity of Topo IV. Helicase assays for T7 gene 4 protein (A) and UvrD (B) in the presence and absence of the wild type and mutant Topo IV and Norf, as indicated, were performed, and the DNA products were analyzed as described under "Materials and Methods." Lane 1 in all panels was heat-denatured substrate. T7 gene 4 protein (as hexamer), UvrD (as dimer), and Topo IV (as tetramer) were present at 25-, 12.5-, and 30-fold molar excess over substrate, respectively. Norf was at 400 M when present. Abbreviations are as in the legend to Fig. 5. appearance of DSBs in the genome. Anticancer drugs that target human type II topoisomerases also convert their targets into poisons (28) .
A number of studies have investigated the molecular mechanisms of cell killing as a result of the action of topoisomerase poisons in both prokaryotic and eukaryotic systems. Formation of topoisomerase-drug-DNA ternary complexes is necessary, but these complexes are normally reversible. An additional step, an active DNA transaction, is required to disrupt the topoisomerase complex and to generate an irreversible cytotoxic DNA lesion (2) (3) (4) . Passage of the replication machinery has been the leading candidate for this disruptive process that triggers lethal events. It has been proposed that when DNA replication occurs in the presence of topoisomerase-drug-DNA ternary complexes, the collision between a replication fork and a ternary complex results in the disruption of topoisomerase complex and the generation of DSBs (2-4) . The recent demonstration of the disruption of an m-AMSA-induced T4 topoisomerase-DNA complex by the UvrD helicase supports this model (23) . However, the molecular events during this collision and the mechanism of DSB formation are not yet clear.
We have studied the consequences of the encounter between a replication fork and a Topo IV-Norf-DNA ternary complex using the oriC replication system (5). Three mutant Topo IVs, ParC Y120F Topo IV, which is catalytically inactive, ParC S80L Topo IV, which is resistant to inhibition by quinolones such as Norf, and the double mutant, ParC S80L,Y120F Topo IV, were used. Only the wild type enzyme was capable of forming a ternary complex with the DNA and Norf that blocked replication fork progression. The ternary complexes formed by a catalytically inactive and a quinolone-resistant Topo IV could not halt progression of the replication fork. Thus, an active strand cleavage and reunion activity of Topo IV was required for the arrest of replication fork progression in vitro by the Topo IV-Norf-DNA ternary complex (5) . Similar studies have been performed demonstrating that a ternary complex formed by wild type DNA gyrase could block transcription by bacterial RNA polymerase (29) .
Here, we continued our studies on the mechanism of replication fork arrest by topoisomerase-quinolone-DNA ternary complexes. Replication forks are composed of a DNA helicase, DNA polymerase, and primase. The replicative helicase is positioned at the front of the replication fork and collides with any roadblocks on the DNA. We investigated the effects of the Topo IV-Norf-DNA ternary complex on DNA helicases. We found that a Topo IV-Norf-DNA ternary complex could block the passage of DnaB, T7 gene 4 protein, SV40 T-ag, and UvrD (Fig.  3) . Interestingly, this general inhibition of DNA helicases did not require the strand cleavage and reunion activity of Topo IV (Fig. 6) . Furthermore, we found that unlike the case with a replication fork, collisions of Topo IV-Norf-DNA ternary complexes with replicative helicases did not affect the reversibility of the ternary complex (Fig. 4) . In contrast, the UvrD helicase could convert the ternary complex to a nonreversible form (Fig. 5) .
The DnaB protein is the replicative helicase in E. coli (10) . We showed here that a Topo IV-Norf-DNA ternary complex formed at a defined Topo IV binding site could halt the passage of DnaB and other hexameric replicative helicases (Fig. 3A) . Inhibition of DnaB translocation may lead to replication fork arrest. Does the encounter of the DnaB helicase alone with a Topo IV-Norf-DNA ternary complex result in the disruption of the topoisomerase complex and the generation of a cytotoxic DNA lesion? This is not likely to be the case. Because the collision between a Topo IV-Norf-DNA ternary complex and the DnaB helicase did not affect the reversibility of the ternary complex (Fig. 4) . In contrast, the encounter of a Topo IV-Norf-DNA ternary complex with a replication fork converted the ternary complex to a nonreversible form (5) . Thus, we concluded that, although the inhibition of DnaB translocation may cause replication fork arrest, the collision of DnaB alone is not sufficient to disrupt the topoisomerase-quinolone-DNA ternary complexes and generate DSBs. We have previously noted that the DnaB helicase changes its sensitivity to the Tus/Ter complex depending on its interaction with other primosomal proteins (9). Kim et al. (22) have demonstrated that the interaction between DnaB and the DNA polymerase III holoenzyme stimulates the rate of DnaB-catalyzed unwinding of the duplex DNA. Observations presented here also showed that there are qualitative differences in the characteristics of DnaB depending on its association with other replication fork components.
What are the differences between the DnaB helicase and a replication fork? Because of the functional interaction between DnaB and the DNA polymerase III holoenzyme, the replication fork progresses much faster than DnaB alone (22) . In addition, the mass of a replication fork is larger than that of a DnaB hexamer. These may be sufficient to account for the abilities of the replication fork to move through a ternary complex formed with a catalytically inactive Topo IV and to convert the wild type Topo IV-Norf-DNA ternary complex to a nonreversible form upon its collision (5) . Another possibility is that DNA polymerase is the active agent that converts the topoisomerasequinolone-DNA ternary complex to a nonreversible form. If this is the case, when a replication fork encounters a ternary complex, the translocation and unwinding of DnaB is presumably halted, and the helicase must disassociate from the DNA. DNA polymerase III continues its progression until it physically contacts the topoisomerase in the ternary complex, and it is this collision that disrupts the topoisomerase complex and converts the ternary complex to a nonreversible form.
We used a catalytically inactive Topo IV, ParC Y120F Topo IV, in the helicase assays and found that the strand cleavage and reunion activity of Topo IV was not required for the inhibition of DNA helicases. The inhibition of DNA helicases by ParC Y120F Topo IV was still dependent on the presence of Norf (Fig. 6) . These results support the previous observations demonstrating that quinolones can act on a topoisomerase and form a ternary complex with the enzyme and the DNA prior to the strand cleavage reaction (6, 29, 30) . It will be interesting to investigate if interactions between the topoisomerase and the drug are identical before and after the strand cleavage reaction.
UvrD was unique among the DNA helicases we examined. Only the encounter of UvrD with a Topo IV-Norf-DNA ternary complex resulted in the conversion of the ternary complex to a nonreversible form (Fig. 5) . It is not clear, at this point, what makes UvrD different from other helicases. One possible explanation for this difference is the distinct modes of helicase action. UvrD is thought to function as a dimer (31) , whereas the three other helicases we used in these studies are hexameric helicases (14 -16) . Thus, UvrD, but not the hexameric DNA helicases, may reach closer to the topoisomerase in the ternary complex and disrupt its conformation. Another possibility, although it is also related to the molecular mechanisms of helicase action during the unwinding of duplex DNA, is that the mode of DNA binding and the stability of the DNA helicase on the DNA are different among helicases. Some DNA helicases, such as UvrD, may interact with both single-stranded and double-stranded DNAs at the junction between the unwound single-stranded DNA and the parental double-stranded DNA (31) . On the other hand, other DNA helicases, such as DnaB and T7 gene 4 protein, may interact with only single-stranded DNA at the junction (14, 16, 32) .
Both a replication fork assembled at oriC and a repair helicase UvrD can convert a Topo IV-Norf-DNA ternary complex to a nonreversible form upon their collisions. It is not clear if both affect the ternary complex in the same manner. We suspect that dead end topoisomerase complexes generated by replication forks may be different from those generated by the UvrD helicase. Collisions between topoisomerase-quinolone-DNA ternary complexes and replication forks do not generate any strand breaks (5) . Denaturation of the topoisomerase was required for the generation of DSBs. In contrast, the collision of UvrD and a T4 topoisomerase-m-AMSA-DNA ternary complex results in the generation of a single strand break (SSB) and leads to the release of a single-stranded DNA from the frozen cleavable complex (23) . We also detected a short DNA strand released from nonreversible Topo IV complexes without denaturing the topoisomerase. 3 However, the generation of SSBs was observed only at a portion (less than 25%) of the frozen cleavable complexes of Topo IV, whereas the conversion of a Topo IV-Norf-DNA ternary complex to a nonreversible form was nearly complete (Fig. 5, lanes 7 and 8) . Thus, it is not clear if the conversion of a Topo IV-Norf-DNA ternary complex to a dead end complex is due to the SSB formation at the ternary complex. Alternatively, differences in stability of the ternary complexes formed with different topoisomerases and drugs may be attributable to the efficiency of the generation of SSBs when UvrDs collide with the topoisomerase-quinolone-DNA ternary complexes.
Let us assume that the mechanisms of disruption of the topoisomerase-quinolone-DNA ternary complexes by the replication fork and UvrD are distinct. This might reflect two different biological processes in the cells. It is interesting to speculate that the encounter of a topoisomerase-quinolone-DNA ternary complex with the UvrD helicase on the chromosome may occur during the removal of the topoisomerase and repair of DNA damage, whereas that with the replication fork may trigger the drug-induced lethal event. A UvrD-directed repair system may recognize the topoisomerase-quinolone-DNA ternary complexes on the chromosome and remove them to prevent the replication fork from colliding with these complexes. If this is the case, the distinct effects of a uvrD mutant on the lethality of DNA gyrase-and Topo IV-targeted quinolone drug action in E. coli (33) may be explained by the time given for the operation of a UvrD-directed repair system and the positioning of topoisomerases relative to the advancing replication forks. It has been suggested that DNA gyrase acts ahead of the advancing replication forks and that Topo IV acts behind them in E. coli (34, 35) . Thus, ternary complexes formed with Topo IV have a greater chance of being removed by repair machinery that includes UvrD before their collisions with replication forks than those with DNA gyrase.
